(Q35554192)

8 August 2017

0 references

Usefulness of Adalimumab for Treating a Case of Intestinal Behçet's Disease With Trisomy 8 Myelodysplastic Syndrome (English)

1 reference

8 August 2017

0 references

0 references

Masamichi Kimura

1

1 reference

8 August 2017

Yoshihisa Tsuji

2

1 reference

8 August 2017

Masako Iwai

3

1 reference

8 August 2017

Masahiro Inagaki

4

1 reference

8 August 2017

Ali Madian

5

1 reference

8 August 2017

Takuya Yoshino

6

1 reference

8 August 2017

Minoru Matsuura

7

1 reference

8 August 2017

Hiroshi Nakase

8

1 reference

8 August 2017

language of work or name

1 reference

27 April 2015

1 reference

8 August 2017

1 reference

8 August 2017

13

1 reference

8 August 2017

2

1 reference

8 August 2017

166-169

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

8 August 2017

start time

1 January 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Refractoriness of intestinal Behçet's disease with myelodysplastic syndrome involving trisomy 8 to medical therapies - our case experience and review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4414759

The 2nd edition of consensus statements for the diagnosis and management of intestinal Behçet's disease: indication of anti-TNFα monoclonal antibodies

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4414759

Adalimumab for the treatment of Behçet's disease: experience in 19 patients

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4414759

Behçet disease associated with myelodysplastic syndrome

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4414759

Myelodysplastic syndrome complicated with inflammatory intestinal ulcers: significance of trisomy 8.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4414759

Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4414759

Trisomy 8 involved in myelodysplastic syndromes as a risk factor for intestinal ulcers and thrombosis--Behçet's syndrome

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4414759

Intestinal Behçet's disease associated with myelodysplastic syndrome with chromosomal trisomy 8--a report of two cases and a review of the literature.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4414759

International scoring system for evaluating prognosis in myelodysplastic syndromes

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4414759

Surgical implications of Behçet's disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4414759

Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behçet's disease.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4414759

Efficacy of infliximab for induction and maintenance of remission in intestinal Behçet's disease

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4414759

Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4414759

Cytokine inhibitors: soluble tumor necrosis factor receptor 1 and interleukin-1 receptor antagonist in Behçet’s disease

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4414759

Treat early and embrace the evidence in favour of anti-TNF-alpha therapy for Behçet's uveitis

26 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25932002

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Evidence for involvement of tumor necrosis factor-alpha in apoptotic death of bone marrow cells in myelodysplastic syndromes

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25932002

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.5217/IR.2015.13.2.166

1 reference

release_juwoxch5hncm5ngk5rsfn6q564

8 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/juwoxch5hncm5ngk5rsfn6q564

mapped directly with Wikidata item

24 November 2022

based on heuristic

PMCID

4414759

1 reference

8 August 2017

1 reference